Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000075

Chief Executive Officer sold 15,730 shares at $26.83 ($421,979)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Congleton Jon Chief Executive Officer 2026-04-13 Sale 10b5-1 −15,730 $26.83 $421,979 689,321 D
Open-market sales · 15,730 sh · avg $26.83 · $421,979
Loading xslF345X06/wk-form4_1776303917.xml…